November 14, 2024CorporateTerumo Blood and Cell Technologies Unlocks New Chapter of Localization in China to Facilitate Blood and Cell Treatment Options for Patients
November 12, 2024CorporateTerumo Blood and Cell Technologies Merges Therapeutics Units to Enhance Patient Care Across Treatment JourneyNew Global Therapy Innovations business unit, led by Veerle d’Haenens, aims to unify therapeutic apheresis and cell and gene therapy expertise to expand therapeutic possibilities
November 07, 2024FinancialNotice Concerning Revisions to Full-Year Consolidated Financial Guidance for Fiscal Year Ending March 31, 2025 (FY2024) (PDF 85.27 KB)
2022 All pages, single page (PDF 13.04 MB) All pages, 2 pages spread (PDF 12.89 MB) Please refer to the ESG Section here.2021 All pages, single page (PDF 22.85 MB) All pages, 2 pages spread (PDF 22.77 MB) 2020 Japanese (PDF 3.47 MB) English (PDF 3 MB) Financial Information (English) (PDF 1.48 MB) 2019 Japanese (PDF 3.36 MB) English (PDF 2.92 MB) Financial Information (English) (PDF 1.5 MB) 2018 Japanese (PDF 2.23 MB) English (PDF 1.97 MB) Financial Information (English) (PDF 1.72 MB) 2017 Japanese (PDF 7.59 MB) English (PDF 6.53 MB) Financial Information (English) (PDF 2.93 MB) DisclaimerAdobe Reader is required for viewing PDF files.Download Adobe Reader
Top
Top